Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation.

about

The construction of the multifunctional targeting ursolic acids liposomes and its apoptosis effects to C6 glioma stem cells.

P2860

Q41964123-3E2CCF9C-EA0C-4AC8-BC54-15C492F3A6D2

P2860

Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation.

Item

http://www.wikidata.org/entity/Q38903218

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Radiolabeled new somatostatin ...... nd radiobiological evaluation.

@en

type

Item

label

Radiolabeled new somatostatin ...... nd radiobiological evaluation.

@en

prefLabel

Radiolabeled new somatostatin ...... nd radiobiological evaluation.

@en

P1476

Radiolabeled new somatostatin ...... nd radiobiological evaluation.

@en

P2093

Indranil Banerjee

http://www.w3.org/2001/XMLSchema#string

Kakali De

http://www.w3.org/2001/XMLSchema#string

Mridula Misra

http://www.w3.org/2001/XMLSchema#string

P2860

Radiopeptide imaging and therapy in the United States

Rationale for the use of somatostatin analogs as antitumor agents

Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review.

Somatostatin receptor imaging.

Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases.

Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor-positive tumor scintigraphy.

Evaluation of (64)Cu-labeled DOTA-D-Phe(1)-Tyr (3)-octreotide ((64)Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors.

[(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate.

Radiolabeling and biological evaluation of DOTA-Ph-Al derivative conjugated to anti-EGFR antibody ior egf/r3 for targeted tumor imaging and therapy.

Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide.

P2888

s00726-015-1942-0

P304

1135-1153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00726-015-1942-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25743164

http://www.w3.org/2001/XMLSchema#string

Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation.

about

P2860

P2860

Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698